NASDAQ:OMDA Omada Health (OMDA) Stock Price, News & Analysis $21.96 -0.16 (-0.72%) As of 09/12/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Omada Health Stock (NASDAQ:OMDA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Omada Health alerts:Sign Up Key Stats Today's Range$21.87▼$22.3550-Day Range$16.85▼$24.2852-Week Range$14.14▼$28.40Volume180,162 shsAverage Volume363,500 shsMarket Capitalization$1.26 billionP/E RatioN/ADividend YieldN/APrice Target$24.50Consensus RatingModerate Buy Company Overview Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching. In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management. The company integrates connected devices—such as smart scales, blood pressure monitors and activity trackers—to monitor participants’ progress and deliver real-time insights. Its multidisciplinary care teams, which include health coaches, registered dietitians and behavioral health specialists, work collaboratively to guide users toward sustainable lifestyle changes and clinical goals. Founded in 2011 and headquartered in San Francisco, Omada Health partners with a range of stakeholders including employers, health plans and healthcare systems across the United States. Through these partnerships, the company aims to reduce the incidence and costs of chronic disease while improving long-term health outcomes. Co-founder and CEO Sean Duffy leads the organization’s strategic vision, overseeing product development and market expansion initiatives.AI Generated. May Contain Errors. Read More Receive OMDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omada Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OMDA Stock News HeadlinesOmada Health, Inc. (OMDA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comOmada Health announces analysis on weight maintenance post GLP-1 discontinuationSeptember 8, 2025 | msn.comAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.September 14 at 2:00 AM | Stansberry Research (Ad)New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry AssumptionsSeptember 8, 2025 | globenewswire.comOmada Health (NASDAQ:OMDA) versus So-Young International (NASDAQ:SY) Head-To-Head ComparisonSeptember 8, 2025 | americanbankingnews.comOmada Health (NASDAQ:OMDA) Now Covered by Robert W. BairdSeptember 7, 2025 | americanbankingnews.comBaird R W Upgrades Omada Health (NASDAQ:OMDA) to "Hold"September 7, 2025 | americanbankingnews.comBaird Initiates Coverage of Omada Health (OMDA) with Neutral RecommendationSeptember 6, 2025 | msn.comSee More Headlines OMDA Stock Analysis - Frequently Asked Questions How have OMDA shares performed this year? Omada Health's stock was trading at $15.74 at the beginning of the year. Since then, OMDA shares have increased by 39.5% and is now trading at $21.96. How were Omada Health's earnings last quarter? Omada Health, Inc. (NASDAQ:OMDA) posted its earnings results on Thursday, August, 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.15) by $0.07. The business had revenue of $61.37 million for the quarter, compared to analysts' expectations of $55.17 million. Read the conference call transcript. When did Omada Health IPO? Omada Health (OMDA) raised $150 million in an initial public offering on Friday, June 6th 2025. The company issued 7,900,000 shares at a price of $19.00 per share. When did the company's quiet period expire? Omada Health's quiet period expired on Wednesday, July 16th. Omada Health had issued 7,900,000 shares in its public offering on June 6th. The total size of the offering was $150,100,000 based on an initial share price of $19.00. During the company's quiet period, insiders and any underwriters involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. Who are Omada Health's major shareholders? Top institutional investors of Omada Health include Perceptive Advisors LLC (9.42%), Loomis Sayles & Co. L P (4.23%), Sanofi (2.04%) and Federated Hermes Inc. (1.94%). How do I buy shares of Omada Health? Shares of OMDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/07/2025Today9/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:OMDA Previous SymbolNASDAQ:OMDA CIK1611115 WebN/A Phone(888) 987-8337FaxN/AEmployees849Year FoundedN/APrice Target and Rating Average Price Target for Omada Health$24.50 High Price Target$29.00 Low Price Target$19.00 Potential Upside/Downside+11.6%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares57,580,000Free FloatN/AMarket Cap$1.26 billion OptionableN/A BetaN/A Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:OMDA) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omada Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omada Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.